✉news HealthMedicine first seen 4 h ago, last 3 h ago, peak #37
Moderna starts Phase 1 trial of Ebola vaccine
Original: Moderna begins Phase 1 clinical trial of Ebola vaccine against strain behind DRC outbreak
Moderna has begun a Phase 1 clinical trial of an Ebola vaccine targeting the Zaire strain responsible for the outbreak in the Democratic Republic of the Congo. The trial marks the first human testing of the candidate, which uses the same mRNA technology behind Moderna's COVID-19 vaccine. Coverage is highlighting the company's growing pipeline and the urgent need for new Ebola countermeasures in central Africa.
Why now: Moderna's move into Ebola vaccine development is new news about a major biotech company addressing an active outbreak.
ModernaEbolaDemocratic Republic of the Congo
Evidence
- Moderna begins Phase 1 clinical trial of Ebola vaccine against strain behind DRC outbreak · ABC News - Breaking News, Latest News and Videos
API: https://socialmediatrends-api.osmike.com/v1/trends/42859